Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Mar 20, 2023

BUY
$42.05 - $47.77 $675,070 - $766,899
16,054 New
16,054 $699 Million
Q1 2022

Mar 21, 2023

BUY
$40.23 - $47.74 $680,812 - $807,904
16,923 New
16,923 $737 Million
Q4 2021

Mar 21, 2023

BUY
$38.88 - $45.31 $557,228 - $649,382
14,332 New
14,332 $632 Million
Q3 2021

Mar 22, 2023

BUY
$38.79 - $43.16 $437,667 - $486,974
11,283 New
11,283 $431 Million
Q2 2021

Mar 22, 2023

BUY
$36.52 - $41.46 $414,100 - $470,114
11,339 New
11,339 $452 Million
Q1 2021

Mar 22, 2023

BUY
$34.27 - $40.01 $409,732 - $478,359
11,956 New
11,956 $427 Million
Q4 2020

Mar 22, 2023

BUY
$34.07 - $39.94 $436,027 - $511,152
12,798 New
12,798 $471 Million
Q3 2020

Mar 22, 2023

BUY
$38.11 - $42.99 $515,323 - $581,310
13,522 New
13,522 $509 Million
Q2 2020

Mar 24, 2023

BUY
$37.87 - $43.58 $8,823 - $10,154
233 Added 1.68%
14,142 $577 Million
Q1 2020

Mar 24, 2023

BUY
$32.47 - $48.83 $451,625 - $679,176
13,909 New
13,909 $527 Million
Q4 2019

Mar 24, 2023

BUY
$42.0 - $48.25 $573,888 - $659,288
13,664 New
13,664 $642 Million
Q3 2019

Mar 24, 2023

BUY
$40.46 - $43.52 $60,204 - $64,757
1,488 Added 12.71%
13,195 $563 Million
Q2 2019

Mar 24, 2023

BUY
$39.4 - $42.7 $461,255 - $499,888
11,707 New
11,707 $469 Million
Q1 2019

Mar 24, 2023

BUY
$38.57 - $42.69 $82,886 - $91,740
2,149 Added 22.64%
11,641 $486 Million
Q4 2018

Mar 24, 2023

SELL
$37.8 - $42.69 $70,912 - $80,086
-1,876 Reduced 16.5%
9,492 $363 Million
Q3 2018

Mar 24, 2023

BUY
$39.75 - $42.69 $451,878 - $485,299
11,368 New
11,368 $457 Million
Q2 2018

Mar 24, 2023

BUY
$39.61 - $42.76 $31,133 - $33,609
786 Added 6.82%
12,308 $496 Million
Q1 2018

Mar 24, 2023

BUY
$36.18 - $40.15 $416,865 - $462,608
11,522 New
11,522 $450 Million
Q4 2017

Mar 24, 2023

BUY
$35.34 - $41.9 $305,443 - $362,141
8,643
8,643 $307 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $67.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.